Zendjabil Mustapha, Favard Séverine, Tse Chantal, Abbou Omar, Hainque Bernard
Service de biochimie, établissement hospitalier universitaire (EHU) d'Oran, 1(er)-Novembre-1954, BP 4166 Ibn Rochd, Oran, Algérie.
Service de biochimie métabolique, hôpitaux universitaires Pitié-Salpêtrière-Charles-Foix, 47, boulevard de l'Hôpital, 75013 Paris, France.
C R Biol. 2017 Feb;340(2):114-131. doi: 10.1016/j.crvi.2016.12.001. Epub 2017 Jan 9.
MicroRNAs are nucleic acids of about twenty nucleotides that regulate about a third of the genome at the post-transcriptional level. Thanks to their different forms of transport, microRNAs are stable and can be detected in biological fluids such as blood, urine, cerebrospinal fluid, or saliva. In addition, the profile of circulating microRNAs is a specific part of the cells in which it is secreted and is modified according to the physiological or pathological conditions of these cells. MicroRNAs therefore appear as biomarkers of interest for many diseases. However, these applications face several challenges because there are currently considerable differences between the sample processing procedures, assay methods, and especially the result standardization strategies. This literature review aims to take stock of the current use of microRNAs as biomarkers mainly in biological fluids and address the perspectives that emerge from the fact that their vesicular circulating forms could be used to assess the state of the cells and the tissues that produce them.
微小RNA是约20个核苷酸的核酸,在转录后水平调控约三分之一的基因组。由于其不同的运输形式,微小RNA很稳定,可在血液、尿液、脑脊液或唾液等生物体液中检测到。此外,循环微小RNA的谱是其分泌细胞的特定组成部分,并根据这些细胞的生理或病理状况而改变。因此,微小RNA似乎是许多疾病的重要生物标志物。然而,这些应用面临若干挑战,因为目前样本处理程序、检测方法,尤其是结果标准化策略之间存在相当大的差异。这篇文献综述旨在评估微小RNA目前主要在生物体液中作为生物标志物的应用情况,并探讨因其囊泡循环形式可用于评估产生它们的细胞和组织状态而出现的前景。